718974616	718974616	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
42032022	42032022	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5780781	5780781	CD	B-NP	O
|	|	CC	I-NP	O
1/15/2003	1/15/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/15/2003	10/15/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NN	I-NP	O
:	:	:	O	O
PNEUMONIA	PNEUMONIA	NN	B-NP	O
,	,	,	O	O
RULE	RULE	NNP	B-NP	O
OUT	OUT	NNP	I-NP	O
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MI	MI	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
CHEST	CHEST	NN	B-NP	O
PAIN	PAIN	NN	I-NP	O
AND	AND	CC	B-NP	O
SHORTNESS	SHORTNESS	NN	I-NP	O
OF	OF	IN	B-PP	O
BREATH	BREATH	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
heroin	heroin	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
times	time	NNS	I-NP	O
several	several	JJ	B-NP	O
weeks	week	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
sometimes	sometimes	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
often	often	RB	I-VP	O
brought	bring	VBN	I-VP	O
on	on	RP	B-PRT	O
by	by	IN	B-PP	O
heroin	heroin	NN	B-NP	B-protein
use	use	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
cocaine	cocaine	NN	B-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
heroin	heroin	NN	I-NP	O
use	use	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
``	``	``	O	O
off	off	IN	B-PP	O
and	and	CC	I-PP	O
on	on	IN	I-PP	O
,	,	,	O	O
''	''	''	O	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
necessarily	necessarily	RB	I-VP	O
worse	worse	VB	I-VP	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
this	this	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
hard	hard	JJ	B-ADJP	O
for	for	IN	B-SBAR	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
describe	describe	VB	I-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
mention	mention	NN	B-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
heavy	heavy	JJ	B-ADJP	O
in	in	IN	B-PP	O
character	character	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
admitted	admit	VBD	B-VP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
chest	ch	JJS	I-NP	O
discomfort	discomfort	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
became	become	VBD	B-VP	O
excited	excite	VBN	I-VP	O
or	or	CC	I-VP	O
agitated	agitate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
described	describe	VBD	B-VP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
as	as	IN	B-PP	O
sharp	sharp	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pain	pain	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
radiate	radiate	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
or	or	CC	I-NP	O
arms	arm	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
heartburn	heartburn	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
six	six	CD	I-NP	O
months	month	NNS	I-NP	O
and	and	CC	I-NP	O
admits	admit	NNS	I-NP	O
to	to	TO	B-VP	O
diet	diet	VB	I-VP	O
noncompliance	noncompliance	NN	B-NP	O
with	with	IN	B-PP	O
salty	salty	NN	B-NP	O
foods	food	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
last	last	JJ	I-NP	O
heroin	heroin	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
go	go	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
without	without	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
withdrawal	withdrawal	NN	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
takes	take	VBZ	B-VP	O
laxatives	laxative	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Occasional	Occasional	JJ	B-NP	O
headache	headache	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
vision	vision	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-	-	HYPH	B-NP	O
heroin	heroin	NN	I-NP	O
currently	currently	RB	B-ADVP	O
,	,	,	O	O
cocaine	cocaine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
times	time	VBZ	B-VP	O
many	many	JJ	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
taken	take	VBN	I-VP	O
no	no	DT	B-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	life	NNS	I-NP	O
in	in	IN	B-PP	O
Ver	Ver	NNP	B-NP	O
La	La	NNP	I-NP	O
A	A	NNP	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
brother	brother	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
disability	disability	NN	B-NP	O
since	since	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
smokes	smoke	VBZ	B-VP	O
one	one	CD	B-NP	O
pack	pack	NN	I-NP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
rarely	rarely	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
use	use	VB	I-VP	O
IV	IV	CD	B-NP	O
drugs	drug	NNS	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.3	97.3	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
95	95	CD	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
190/110	190/110	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seated	seat	VBN	I-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Conjunctiva	Conjunctiva	NNP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
pink	pink	JJ	I-ADJP	O
but	but	CC	I-ADJP	O
nonicteric	nonicteric	JJ	I-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
7	7	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
some	some	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
midway	midway	VBP	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Markedly	Markedly	RB	B-NP	O
hypoactive	hypoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
belly	belly	RB	B-ADVP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
obese	obese	JJ	I-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

NEUROLOGIC	NEUROLOGIC	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	B-protein
x	x	NN	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Neural	Neural	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
21	21	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.1	2.1	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
107	107	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.4	8.4	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
158	158	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
was	be	VBD	B-VP	O
0.12	0.12	CD	B-NP	O
.	.	.	O	O

Toxicology	Toxicology	NN	B-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
toxicology	toxicology	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
opiates	opiate	NNS	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
6.9	6.9	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
45.7	45.7	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
301	301	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
was	be	VBD	B-VP	O
13.2	13.2	CD	B-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
32.6	32.6	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
rate	rate	NN	I-NP	O
at	at	IN	B-PP	O
156	156	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
vs	vs	IN	B-PP	O
flutter	flutter	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
axis	axis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	NN	I-NP	O
leads	lead	VBZ	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
V5	V5	NN	B-NP	B-protein
and	and	CC	I-NP	O
V6	V6	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
repeated	repeat	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
diltiazem	diltiazem	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
86	86	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
AVL	AVL	NN	B-NP	O
and	and	CC	I-NP	O
V6	V6	NN	I-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
borderline	borderline	JJ	B-NP	O
first-degree	first-degree	JJ	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
LVH	LVH	NN	B-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
were	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
inferiorly	inferiorly	RB	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
-	-	HYPH	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
CKs	CK	NNS	B-NP	B-protein
but	but	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
which	which	WDT	B-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
0.12	0.12	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
rate	rate	NN	B-NP	O
related	relate	VBN	B-ADJP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
with	with	IN	B-PP	O
verapamil	verapamil	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
bronchospasms	bronchospasm	NNS	I-NP	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
or	or	CC	O	O
real	real	JJ	B-NP	O
bronchospastic	bronchospastic	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

,	,	,	O	O
clonidine	clonidine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
losartan	losartan	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	PDT	B-NP	O
The	The	DT	I-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
desaturation	desaturation	NN	I-NP	O
to	to	TO	B-VP	O
captopril	captopril	VB	I-VP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Aspirin	Aspirin	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
lipid	lipid	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
of	of	IN	B-PP	O
188	188	CD	B-NP	O
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
130	130	CD	I-NP	I-protein
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
56	56	CD	I-NP	I-DNA
and	and	CC	O	O
triglycerides	triglyceride	NNS	B-NP	O
of	of	IN	B-PP	O
63	63	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
simvastatin	simvastatin	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
worry	worry	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
LVEF	LVEF	NN	B-NP	B-protein
only	only	RB	B-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
inferior/posterior	inferior/posterior	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chemical	chemical	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
but	but	CC	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
close	close	RB	B-ADVP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ischemic	ischemic	JJ	B-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
indication	indication	NN	I-NP	O
seen	see	VBN	B-VP	O
for	for	IN	B-PP	O
AICD	AICD	NN	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
central	central	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
and	and	CC	I-NP	O
simvastatin	simvastatin	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
given	give	VBN	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
sake	sake	NN	I-NP	O
of	of	IN	B-PP	O
simplifying	simplify	VBG	B-VP	O
his	his	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
optimize	optimize	VB	I-VP	O
the	the	DT	B-NP	O
chance	chance	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
severe	severe	JJ	I-NP	O
bronchospastic	bronchospastic	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
so	so	RB	B-NP	O
this	this	DT	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
nebulizers	nebulizer	NNS	B-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
clock	clock	NN	I-NP	O
for	for	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
wheeze	wheeze	NN	I-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cough	cough	NN	I-NP	O
was	be	VBD	B-VP	O
after	after	IN	B-SBAR	O
his	his	PRP$	B-NP	O
captopril	captopril	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
changed	change	VBN	B-VP	O
to	to	TO	B-VP	O
losartan	losartan	VB	I-VP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid-2s	mid-2	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid-1s	mid-1	NNS	I-NP	O
.	.	.	O	O

Potential	Potential	JJ	B-NP	O
etiologies	etiology	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
where	where	WRB	B-ADVP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
heroin	heroin	NN	B-NP	O
use	use	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
flow	flow	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
phenol	phenol	NN	I-NP	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
24-hour	24-hour	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBN	B-VP	O
over	over	IN	B-NP	O
3	3	CD	I-NP	O
gm	gm	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
proteinuria	proteinuria	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
CHF	CHF	NNP	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
renal	renal	JJ	B-ADJP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
Mucomyst	Mucomyst	NN	B-NP	O
in	in	IN	B-PP	O
anticipation	anticipation	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
increased	increase	VBN	B-NP	O
echogenicity	echogenicity	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
medical	medical	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
cysts	cyst	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
renal	renal	JJ	I-NP	O
calculus	calculus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Doles	Doles	NNP	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heroin	Heroin	NN	B-NP	O
addiction	addiction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
LCMC	LCMC	NN	I-NP	B-DNA
team	team	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
heroin	heroin	NN	B-NP	O
addiction	addiction	NN	I-NP	O
.	.	.	O	O

Methadone	Methadone	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
to	to	TO	B-PP	O
off	off	RP	B-PRT	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Other	Other	JJ	B-ADJP	O
.	.	.	O	O

Allopurinol	Allopurinol	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
subcu	subcu	NN	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Boddorf	Boddorf	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
August	August	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Dunegan	Dunegan	NNP	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
PM	PM	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Allopurinol	Allopurinol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
losartan	losartan	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
wheeze	wheeze	NN	I-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
torsemide	torsemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
Dictated	Dictated	NNP	B-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GROVER	GROVER	NNP	B-NP	O
PREFONTAINE	PREFONTAINE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PI36	PI36	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JUDE	JUDE	NNP	B-NP	O
PETTER	PETTER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TZ64	TZ64	NNP	I-NP	O
YA777/064994	YA777/064994	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
34715	34715	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

IZOY2Z3RMR	IZOY2Z3RMR	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/8/03	9/8/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/8/03	9/8/03	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DR.	DR.	NNP	B-NP	O
VANPELT	VANPELT	NNP	I-NP	O
,	,	,	O	O
AT	AT	NNP	B-NP	O
INA	INA	NNP	I-NP	O
UNIVERSITY	UNIVERSITY	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O

